Dr James Seddon MBBS MA MRCPCH DTM&H PGDipPID
- Desmond Tutu TB Centre
- Desmond Tutu TB Centre
- Francie Van Zyl Road, Tygerberg
- Cape Town
- 7507
- T: +27 21 938 9685
James Seddon trained in medicine at Corpus Christi College, Cambridge and at Imperial College, London. Following paediatric training at Guys' and St. Thomas' Hospitals in London, he undertook the Diploma in Hygiene and Tropical Medicine at the LSHTM. Nine months in Cote D'Ivoire with MSF and three months on an expedition in Patagonia preceeded core paediatric registrar training in the Severn Deanery. He is currently undertaking a PhD based in Cape Town, South Africa studying multidrug-resistant tuberculosis in children.
Affiliation
Research
His research focuses on the identification, diagnosis, referral and treatment of children both with MDR-TB infection and disease. He is also involved in the study of second-line TB drugs in children.
Research areas
- Child health
- Clinical care
- Drug resistance
Disciplines
- Epidemiology
- Medicine
Disease and Health Conditions
- Infectious disease
- Tuberculosis
Regions
- Sub-Saharan Africa (all income levels)
Countries
- South Africa
Other interests
- MARCH
- TB Centre
-
Selected publications
-
Culture-Confirmed Multidrug-Resistant Tuberculosis in Children: Clinical Features, Treatment, and Outcome
Seddon, J.A.; Hesseling, A.C.; Willemse, M.; Donald, P.R.; Schaaf, H.S.
Clinical Infectious Diseases, 2012; 54(2):157-166
-
Management of children exposed to multidrug-resistant Mycobacterium tuberculosis.
Seddon, J.A. ; Godfrey-Faussett, P. ; Hesseling, A.C. ; Gie, R.P. ; Beyers, N. ; Schaaf, H.S. ;
Lancet Infect Dis, 2012;
-
Impact of Drug Resistance on Clinical Outcome in Children with Tuberculous Meningitis.
Seddon, J.A. ; Visser, D.H. ; Bartens, M. ; Jordaan, A.M. ; Victor, T.C. ; van Furth, A.M. ; Schoeman, J.F. ; Schaaf, H.S. ;
Pediatr Infect Dis J, 2012;
-
Discordant drug susceptibility for Mycobacterium tuberculosis within families.
Seddon, J.A. ; Jordaan, A.M. ; Victor, T.C. ; Schaaf, H.S. ;
Pediatr Infect Dis J, 2012;
-
Pharmacokinetics of Isoniazid, Rifampin, and Pyrazinamide in Children Younger than Two Years of Age with Tuberculosis: Evidence for Implementation of Revised World Health Organization Recommendations
Thee, S.; Seddon, J.A.; Donald, P.R.; Seifart, H.I.; Werely, C.J.; Hesseling, A.C.; Rosenkranz, B.; Roll, S.; Magdorf, K.; Schaaf, H.S.
Antimicrobial Agents and Chemotherapy, 2011; 55(12):5560-5567
-
Paediatric use of second-line anti-tuberculosis agents: A review.
Seddon, J.A. ; Hesseling, A.C. ; Marais, B.J. ; McIlleron, H. ; Peloquin, C.A. ; Donald, P.R. ; Schaaf, S.H. ;
Tuberculosis (Edinb), 2011;
- → View all Dr James Seddon's publications
